Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results

…, R Dodel, B Dubois, R Holloway… - … : official journal of the …, 2008 - Wiley Online Library
We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled …

…, A Clamp, G Scambia, A Leary, RW Holloway… - The Lancet, 2017 - thelancet.com
Background Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in
recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-…

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on …

…, C Counsell, N Giladi, RG Holloway… - Movement …, 2004 - Wiley Online Library
The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD)
prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its …

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan

…, BC Tilley, R Dodel, B Dubois, R Holloway… - Movement …, 2007 - Wiley Online Library
This article presents the revision process, major innovations, and clinimetric testing program
for the Movement Disorder Society (MDS)–sponsored revision of the Unified Parkinson's …

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

RG Holloway, I Shoulson, S Fahn, K Kieburtz… - Archives of …, 2004 - europepmc.org
Objective To compare initial treatment with pramipexole vs levodopa in early Parkinson
disease, followed by levodopa supplementation, with respect to the development of …

A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke …

LH Schwamm, RG Holloway, P Amarenco… - Stroke, 2009 - Am Heart Assoc
The aim of this new statement is to provide a comprehensive and evidence-based review of
the scientific data evaluating the use of telemedicine for stroke care delivery and to provide …

Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients

SA Norton, LA Hogan, RG Holloway… - Critical care …, 2007 - journals.lww.com
Objective: The purpose of this study was to examine the effect of proactive palliative care
consultation on length of stay for high-risk patients in the medical intensive care unit (MICU). …

Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations

RW Holloway, NR Abu-Rustum, FJ Backes… - Gynecologic …, 2017 - Elsevier
The emphasis in contemporary medical oncology has been “precision” or “personalized”
medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar …

Single-arm phases 1 and 2 trial of niraparib in combination with pembrolizumab in patients with recurrent platinum-resistant ovarian carcinoma

…, GA Vidal, M Mita, JW Moroney, R Holloway… - JAMA …, 2019 - jamanetwork.com
Importance Patients with recurrent ovarian carcinoma frequently develop resistance to
platinum-based chemotherapy, at which time treatment options become limited. Objective To …

Association between stroke center hospitalization for acute ischemic stroke and mortality

Y Xian, RG Holloway, PS Chan, K Noyes, MN Shah… - Jama, 2011 - jamanetwork.com
Context Although stroke centers are widely accepted and supported, little is known about
their effect on patient outcomes. Objective To examine the association between admission to …